173 related articles for article (PubMed ID: 24142529)
1. NQO1 C609T polymorphism is associated with esophageal cancer risk among Chinese: a meta-analysis.
Zhao HY; Gu Y; Yi YX
Tumour Biol; 2014 Mar; 35(3):2199-203. PubMed ID: 24142529
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of the NAD(P)H: quinine oxidoreductase 1 gene 609 C>T polymorphism with esophageal cancer risk.
Wang Z; Hu J; Zhong J
DNA Cell Biol; 2012 Apr; 31(4):560-7. PubMed ID: 22017531
[TBL] [Abstract][Full Text] [Related]
3. Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population.
Zhang J; Schulz WA; Li Y; Wang R; Zotz R; Wen D; Siegel D; Ross D; Gabbert HE; Sarbia M
Carcinogenesis; 2003 May; 24(5):905-9. PubMed ID: 12771035
[TBL] [Abstract][Full Text] [Related]
4. Association between NQO1 C609T polymorphism and colorectal cancer risk.
Wang Y; Zhang G; Luo Y
Tumour Biol; 2013 Dec; 34(6):4027-32. PubMed ID: 23893397
[TBL] [Abstract][Full Text] [Related]
5. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T gene polymorphism association with digestive tract cancer: a meta-analysis.
Zhu CL; Huang Q; Liu CH; Lin XS; Xie F; Shao F
Asian Pac J Cancer Prev; 2013; 14(4):2349-54. PubMed ID: 23725139
[TBL] [Abstract][Full Text] [Related]
6. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis.
Lou Y; Li R; Xiong L; Gu A; Shi C; Chu T; Zhang X; Gu P; Zhong H; Wen S; Han B
Tumour Biol; 2013 Dec; 34(6):3967-79. PubMed ID: 23852860
[TBL] [Abstract][Full Text] [Related]
7. NQO1 C609T polymorphism and esophageal cancer risk: a HuGE review and meta-analysis.
Yanling H; Yuhong Z; Wenwu H; Lei X; Mingwu C
BMC Med Genet; 2013 Mar; 14():31. PubMed ID: 23497461
[TBL] [Abstract][Full Text] [Related]
8. Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis.
Gong M; Yi Q; Wang W
Tumour Biol; 2013 Oct; 34(5):2551-6. PubMed ID: 23749485
[TBL] [Abstract][Full Text] [Related]
9. Role of NQO1 609C>T and NQO2 -3423G>A gene polymorphisms in esophageal cancer risk in Kashmir valley and meta analysis.
Malik MA; Zargar SA; Mittal B
Mol Biol Rep; 2012 Sep; 39(9):9095-104. PubMed ID: 22736108
[TBL] [Abstract][Full Text] [Related]
10. Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-analysis.
Liu K; Tian H; Yu KZ; Shen WY; Mao ZC; Jin CH; Pan HB; He JX
Tumour Biol; 2014 Mar; 35(3):2063-8. PubMed ID: 24213850
[TBL] [Abstract][Full Text] [Related]
11. "NQO1 Gene C609T Polymorphism (dbSNP: rs1800566) and Digestive Tract Cancer Risk: A Meta-Analysis.".
Yadav U; Kumar P; Rai V
Nutr Cancer; 2018; 70(4):557-568. PubMed ID: 29652514
[TBL] [Abstract][Full Text] [Related]
12. Association of the NQO1 C609T polymorphism with Alzheimer's disease in Chinese populations: a meta-analysis.
Luo J; Li S; Qin X; Peng Q; Liu Y; Yang S; Qin X; Xiong Y; Zeng Z
Int J Neurosci; 2016; 126(3):199-204. PubMed ID: 25562627
[TBL] [Abstract][Full Text] [Related]
13. NAD(P)H quinone oxidoreductase 1 (NQO1) genetic C609T polymorphism is associated with the risk of digestive tract cancer: a meta-analysis based on 21 case-control studies.
Yang FY; Guan QK; Cui YH; Zhao ZQ; Rao W; Xi Z
Eur J Cancer Prev; 2012 Sep; 21(5):432-41. PubMed ID: 22387672
[TBL] [Abstract][Full Text] [Related]
14. Lack of association between NADPH quinone oxidoreductase 1 (NQO1) gene C609T polymorphism and lung cancer: a case-control study and a meta-analysis.
Guo S; Gao M; Li X; Li Y; Chu S; Zhu D; Niu W
PLoS One; 2012; 7(10):e47939. PubMed ID: 23110137
[TBL] [Abstract][Full Text] [Related]
15. The association between NQO1 Pro187Ser polymorphism and bladder cancer susceptibility: a meta-analysis of 15 studies.
Yang S; Jin T; Su HX; Zhu JH; Wang DW; Zhu SJ; Li S; He J; Chen YH
PLoS One; 2015; 10(1):e0116500. PubMed ID: 25602258
[TBL] [Abstract][Full Text] [Related]
16. The NQO1 C609T polymorphism and risk of lung cancer: a meta-analysis.
Liu Y; Zhang D
Asian Pac J Cancer Prev; 2011; 12(11):3091-5. PubMed ID: 22393995
[TBL] [Abstract][Full Text] [Related]
17. Association between the NQO1 C609T polymorphism with hepatocellular carcinoma risk in the Chinese population.
Zhao H; Zou LW; Zheng SS; Geng XP
Asian Pac J Cancer Prev; 2015; 16(5):1821-5. PubMed ID: 25773831
[TBL] [Abstract][Full Text] [Related]
18. [The NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and susceptibility to esophageal cancer].
Zhang JH; Li Y; Wang R; Sarbia M; Guo W; Wen DG; Wei LZ; Chen ZF; Kuang G; Zhang LW; He M; Wu ML; Wang SJ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):544-6. PubMed ID: 14669229
[TBL] [Abstract][Full Text] [Related]
19. The NAD(P)H: quinine oxidoreductase 1 (NQO1) gene 609 C>T polymorphism is associated with gastric cancer risk: evidence from a case-control study and a meta-analysis.
Hu WG; Hu JJ; Cai W; Zheng MH; Zang L; Wang ZT; Zhu ZG
Asian Pac J Cancer Prev; 2014; 15(5):2363-7. PubMed ID: 24716985
[TBL] [Abstract][Full Text] [Related]
20. Association between NQO1 C609T polymorphism and acute lymphoblastic leukemia risk: evidence from an updated meta-analysis based on 17 case-control studies.
Li C; Zhou Y
J Cancer Res Clin Oncol; 2014 Jun; 140(6):873-81. PubMed ID: 24488035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
